Literature DB >> 28935006

Novel H-shunt Venovenous Bypass for Liver Transplantation in Cynomolgus Macaques.

Yojiro Kato1, Adam D Griesemer1, Anette Wu2, Hugo P Sondermeijer2, Joshua I Weiner1, Raimon Duran-Struuck1, Mercedes Martinez3, Andrea R Slate4, Alexander Romanov4, Jay H Lefkowitch5, Megan Sykes2, Tomoaki Kato6.   

Abstract

Cynomolgus monkeys are often used in preclinical transplantation research. Performing liver transplantation in cynomolgus monkeys is challenging because they poorly tolerate portal vein clamping during the anhepatic phase. Finding an alternative to portal vein clamping is necessary before preclinical liver transplant models can be performed with reliable outcomes. We used 3 different techniques to perform 5 liver transplants in male cynomolgus macaques (weight, 7.4-10.8 kg; mismatched for MHC I and II; matched for ABO). In procedure A, we clamped the portal vein briefly, as in human transplants, as well as the superior mesentery artery to minimize congestion at the expense of temporary ischemia (n = 2). In procedure B, we performed a temporary portocaval shunt with extracorporeal venovenous bypass (n = 1). For procedure C, we developed an H-shunt system (modified portocaval shunt) with extracorporeal bypass (n = 2). Postoperative immunosuppression comprised cyclosporine A, mycophenolate mofetil, and steroids. Recipients in procedure A developed hemodynamic instability and were euthanized within 2 d. The recipient that underwent procedure B was euthanized within 11 d due to inferior vena caval thrombosis. The H-shunt in procedure C led to minimal PV congestion during the anhepatic phase, and both recipients reached the 21-d survival endpoint with good graft function. Our novel H-shunt bypass system resulted in successful liver transplantation in cynomolgus macaques, with long-term posttransplant survival possible. This technical innovation makes possible the use of cynomolgus monkeys for preclinical liver transplant tolerance models.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28935006      PMCID: PMC5621572     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  13 in total

1.  CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates.

Authors:  Tatsuo Kawai; Hiroshi Sogawa; Svetlan Boskovic; Gregory Abrahamian; Rex-Neal Smith; Siew-Lin Wee; David Andrews; Ognjenka Nadazdin; Ichiro Koyama; Megan Sykes; Henry J Winn; Robert B Colvin; David H Sachs; A Benedict Cosimi
Journal:  Am J Transplant       Date:  2004-09       Impact factor: 8.086

2.  Long-term hepatic allograft acceptance based on CD40 blockade by ASKP1240 in nonhuman primates.

Authors:  T Oura; K Yamashita; T Suzuki; D Fukumori; M Watanabe; G Hirokata; K Wakayama; M Taniguchi; T Shimamura; T Miura; K Okimura; K Maeta; H Haga; K Kubota; A Shimizu; F Sakai; H Furukawa; S Todo
Journal:  Am J Transplant       Date:  2012-03-15       Impact factor: 8.086

3.  A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates.

Authors:  M Monden; M Gotoh; T Kanai; L A Valdivia; K Umeshita; W Endoh; Y Nakano; M Kawai; H Ohzato; T Ukei
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

4.  Tolerance induction by liver grafting and FK 506 treatment in nonhuman primates.

Authors:  M Gotoh; M Monden; T Kanai; K Umeshita; K Wang; T Ukei; K Dono; T Tono; M Murata; J Tanimoto
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

5.  Comprehensive characterization of MHC class II haplotypes in Mauritian cynomolgus macaques.

Authors:  Shelby L O'Connor; Alex J Blasky; Chad J Pendley; Ericka A Becker; Roger W Wiseman; Julie A Karl; Austin L Hughes; David H O'Connor
Journal:  Immunogenetics       Date:  2007-03-24       Impact factor: 2.846

6.  New model of veno-venous bypass for management of anhepatic phase in experimental study on dogs.

Authors:  Z Chkhaidze; N Khodeli; O Pilishvili; D Partsakhashvili; M Jangavadze; D Kordzaia
Journal:  Transplant Proc       Date:  2013-06       Impact factor: 1.066

7.  A technique for orthotopic liver transplantation in cynomolgus monkeys.

Authors:  Tetsu Oura; Kenichiro Yamashita; Tomomi Suzuki; Masaaki Watanabe; Gentaro Hirokata; Kenji Wakayama; Masahiko Taniguchi; Tsuyoshi Shimamura; Hiroyuki Furukawa; Satoru Todo
Journal:  Transplantation       Date:  2014-09-27       Impact factor: 4.939

8.  Paneth cell-derived interleukin-17A causes multiorgan dysfunction after hepatic ischemia and reperfusion injury.

Authors:  Sang Won Park; Mihwa Kim; Kevin M Brown; Vivette D D'Agati; H Thomas Lee
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

9.  Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy.

Authors:  Sang Won Park; Sean W C Chen; Mihwa Kim; Kevin M Brown; Jay K Kolls; Vivette D D'Agati; H Thomas Lee
Journal:  Lab Invest       Date:  2010-08-09       Impact factor: 5.662

10.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; A Benedict Cosimi; Thomas R Spitzer; Nina Tolkoff-Rubin; Manikkam Suthanthiran; Susan L Saidman; Juanita Shaffer; Frederic I Preffer; Ruchuang Ding; Vijay Sharma; Jay A Fishman; Bimalangshu Dey; Dicken S C Ko; Martin Hertl; Nelson B Goes; Waichi Wong; Winfred W Williams; Robert B Colvin; Megan Sykes; David H Sachs
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

View more
  6 in total

1.  Transient Mixed Chimerism With Nonmyeloablative Conditioning Does Not Induce Liver Allograft Tolerance in Nonhuman Primates.

Authors:  Sulemon Chaudhry; Yojiro Kato; Joshua Weiner; Paula Alonso-Guallart; Sam Baker; David C Woodland; Jay H Lefkowitch; Raimon Duran-Struuck; Hugo P Sondermeijer; Jonah Zitsman; Mallory L Sears; Anette Wu; Brian Karolewski; Philipp J Houck; Mercedes Martinez; Tomoaki Kato; Megan Sykes; Adam D Griesemer
Journal:  Transplantation       Date:  2020-04-06       Impact factor: 4.939

2.  Up-regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation.

Authors:  Takahiro Tomiyama; Takuya Yamamoto; Shokichi Takahama; Takeo Toshima; Shinji Itoh; Noboru Harada; Mototsugu Shimokawa; Daisuke Okuzaki; Masaki Mori; Tomoharu Yoshizumi
Journal:  Hepatol Commun       Date:  2022-07-27

Review 3.  Transplantation tolerance in nonhuman primates and humans.

Authors:  Megan Sykes; Adam D Griesemer
Journal:  Bone Marrow Transplant       Date:  2019-08       Impact factor: 5.483

4.  Transient-mixed Chimerism With Nonmyeloablative Conditioning Does Not Induce Liver Allograft Tolerance in Nonhuman Primates.

Authors:  Sulemon Chaudhry; Yojiro Kato; Joshua Weiner; Paula Alonso-Guallart; Sam Baker; David C Woodland; Jay H Lefkowitch; Raimon Duran-Struuck; Hugo P Sondermeijer; Jonah Zitsman; Mallory L Sears; Anette Wu; Brian Karolewski; Philipp J Houck; Mercedes Martinez; Tomoaki Kato; Megan Sykes; Adam D Griesemer
Journal:  Transplantation       Date:  2020-08       Impact factor: 5.385

5.  Long-Term Outcome and Rejection After Allogeneic Uterus Transplantation in Cynomolgus Macaques.

Authors:  Iori Kisu; Hirohito Ishigaki; Katsura Emoto; Yojiro Kato; Yohei Yamada; Kentaro Matsubara; Hideaki Obara; Yohei Masugi; Yusuke Matoba; Masataka Adachi; Kouji Banno; Yoko Saiki; Iori Itagaki; Ikuo Kawamoto; Chizuru Iwatani; Takahiro Nakagawa; Hideaki Tsuchiya; Takako Sasamura; Hiroyuki Urano; Masatsugu Ema; Kazumasa Ogasawara; Daisuke Aoki; Kenshi Nakagawa; Takashi Shiina
Journal:  J Clin Med       Date:  2019-10-01       Impact factor: 4.241

6.  Characterization of 100 extended major histocompatibility complex haplotypes in Indonesian cynomolgus macaques.

Authors:  Cecilia G Shortreed; Roger W Wiseman; Julie A Karl; Hailey E Bussan; David A Baker; Trent M Prall; Amelia K Haj; Gage K Moreno; Maria Cecilia T Penedo; David H O'Connor
Journal:  Immunogenetics       Date:  2020-02-29       Impact factor: 2.846

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.